Chapter 13. Nuclear Receptors as Targets in Cardiovascular Diseases
- Prof. Dr. Eckhard Ottow3,
- Dr. Hilmar Weinmann4
Published Online: 19 DEC 2008
DOI: 10.1002/9783527623297.ch13
Copyright © 2008 Wiley-VCH Verlag GmbH & Co. KGaA
Book Title

Nuclear Receptors as Drug Targets
Additional Information
How to Cite
Kolkhof, P., Bärfacker, L., Hillisch, A., Haning, H. and Schäfer, S. (2008) Nuclear Receptors as Targets in Cardiovascular Diseases, in Nuclear Receptors as Drug Targets (eds E. Ottow and H. Weinmann), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527623297.ch13
Editor Information
- 3
Bayer Schering Pharma AG, Medicinal Chemistry (S106/345), Müllerstrasse 178, 13342 Berlin, Germany
- 4
Bayer Schering Pharma AG, Medicinal Chemistry (S106/048A), Müllerstrasse 178, 13342 Berlin, Germany
Publication History
- Published Online: 19 DEC 2008
- Published Print: 20 AUG 2008
Book Series:
Book Series Editors:
- Prof. Dr. Raimund Mannhold5,
- Prof. Dr. Hugo Kubinyi6,
- Prof. Dr. Gerd Folkers7
Series Editor Information
- 5
Molecular Drug Research Group, Heinrich-Heine-Universität, Universitätsstrasse 1, 40225 Düsseldorf, Germany
- 6
Donnersbergerstrasse 9, 67256 Weisenheim am Sand, Germany
- 7
Collegium Helveticum, STW/ETH Zurich, 8092 Zurich, Switzerland
ISBN Information
Print ISBN: 9783527318728
Online ISBN: 9783527623297
- Summary
- Chapter
- References
Keywords:
- mineralocorticoid receptor;
- thyroid hormone receptors;
- peroxisome proliferator-activated receptor α;
- heart failure
Summary
This chapter contains sections titled:
Introduction
MR (NR3C2)
THRs (NR1A1 and NR1A2)
PPARα (NR1C1)
VDR (NR1I1)
Retinoic Acid Receptors (NR1B1, 2 and 3) and Retinoid X Receptors (NR2B1, 2 and 3)
Liver X Receptors (NR1H3 and NR1H2)
Outlook
References
